Skip to main content
. 2008 Jan 21;153(7):1579–1586. doi: 10.1038/sj.bjp.0707685

Table 3.

Genotype frequency and gliclazide CL/F in 21 subjects in gliclazide only phase

CYP2C9 genotype Samples (n) Frequency (%) Gliclazide CL/F (ml h−1 kg−1)
*1/*1 11 52.4 24.0 (19.0–28.9)
*1/*2 or 6 28.6 18.5 (15.2–21.7)
*2/*2 1 4.8  
*1/*3 3 14.3 25.4 (20.4–30.5)

Abbreviation: CL/F, apparent clearance.

Data shown was not to represent population frequency; data are presented as median and range.